Cargando…
Myxedema Coma: A Life-Threatening Condition in Patients Using Pembrolizumab
The advent of immune checkpoint inhibitors has significantly improved the prognosis of patients with advanced malignancies. As we begin to understand these medications, multiple immune-related adverse effects (irAEs) have been found with these drugs, including endocrinopathies. Understanding the tre...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599411/ https://www.ncbi.nlm.nih.gov/pubmed/33145114 http://dx.doi.org/10.1155/2020/8855943 |